Public offerings

AMC Entertainment Holdings, Inc. (NYSE:AMC) ("AMC" or "the Company"), announced today that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 95,250,000 shares of AMC common stock. The Offering is expected to result in gross proceeds of approximately $200 million, before deducting agent fees and offering expenses. AMC intends to use the net proceeds from the Offering to redeem all of its $125,500,000 aggregate principal amount of 6.125% Senior Subordinated Notes due 2027, pay related fees, costs, premiums and expenses associated therewith and for general corporate purposes, which may include the repayment of other d

Stokes was one of 22 financial leaders recognized in the Greater Houston areaFRIENDSWOOD, Texas, June 23, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced that Frank Stokes, its chief financial officer, has been named a 2026 CFO Awards honoree by the Houston Business Journal. Stokes is among 22 chief financial officers from across the Greater Houston area recognized for their financial leadership and contributions to their organizations' success. Honorees will be celebrated a

MIAMI BEACH, FL, June 23, 2026 /CNW/ - GFL Environmental Inc. (NYSE:GFL) (TSX:GFL) ("GFL" or the "Company") today announced the pricing of US$750 million in aggregate principal amount of senior notes due 2031 (the "Notes"), with a stated coupon of 5.625% or approximately 4.500% after giving effect to cross currency interest rate swaps the Company intends to enter into (the "Notes Offering"). The Notes will be issued by a U.S. wholly owned subsidiary of GFL and will be guaranteed by GFL and certain of its other subsidiaries. GFL intends to use the proceeds from the Notes Offering to repay amounts drawn on its revolving credit fa

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common stock upon conversion of the notes JUPITER, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) ("Ligand") announced today the pricing of $625.0 million aggregate principal amount of 0.0% convertible senior notes due 2031 (the "notes") in a private placement (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Sec

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/TORONTO and LAS VEGAS, June 22, 2026 /CNW/ - Bragg Gaming Group (NASDAQ:BRAG) (TSX:BRAG) ("bragg" or the "Company"), a leading iGaming content and platform technology solutions provider, today announced the closing of its previously announced non-brokered private placement of 751,445 subscription receipts (the "Subscription Receipts") at a price of US$1.73 per Subscription Receipt for aggregate gross proceeds of approximately US$1,300,000 (the "Offering"). The issue price of US$1.73 per Subscription Receipt was based on the closing price of the common shares of the Company (the "Shares") on the

RALEIGH, N.C., June 22, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (NASDAQ:CDNL) today announced a proposed, underwritten public offering of its Class A common stock. The offering consists of 3,750,000 shares of Class A common stock being offered by the Company. All shares as a part of the proposed offering are being offered by Cardinal.  In addition, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 562,500 shares of Class A common stock at the public offering price, less underwriting discounts and commissions.

Marks Significant Step in Wind-Down of Healthcare OperationsNakamoto Inc. (NASDAQ:NAKA) ("Nakamoto" or the "Company") today announced that its healthcare clinics concluded operations on June 19, 2026. Additional administrative activities associated with the wind-down of the Company’s legacy healthcare business are expected to be completed in the third quarter of 2026.The clinic closure reflects the Company’s full transition to a Bitcoin operating company focused on media & information services, asset management & financial services, and consulting & advisory services, designed to generate recurring revenue and support continued growth across the verticals."With our healthcare clinics now clo

$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon the exercise in full of warrantsTEL AVIV, Israel and RALEIGH, N.C., June 22, 2026 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of its previously announced private placement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the Company, series A-1 warrants to purchase up to an aggregate of 8,571,429 ADSs and series A-2 warrants to purchase up to an ag

Calls on the Board to Engage Constructively with Shareholders to Address Governance Concerns and Protect Long-term Shareholder Value  ISS, An Independent Proxy Advisor, Recommends Shareholders Vote Against the Brera Board NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- RBCH Ltd. ("RBCH"), a 10%+ shareholder of Brera Holdings PLC (d/b/a Solmate Infrastructure) (NASDAQ:SLMT) ("Brera" or the "Company"), today announced that it has filed a derivative lawsuit, on behalf of the Company, against its current officers and directors (the "Defendants"), for breach of fiduciary duty, shareholder oppression, and related claims arising from a systematic pattern of self-dealing that has caused tens of mil

Joe Jordan to Become Chief Executive OfficerRussell Weiner to Retire as CEO and Become Executive ChairmanDavid Brandon to Retire from the Board Following 28 Years of ServiceANN ARBOR, Mich., June 22, 2026 /PRNewswire/ -- Domino's Pizza Inc. (NASDAQ:DPZ), the largest pizza company in the world, today announced that Russell Weiner has informed the Company's Board of Directors of his intention to retire as Chief Executive Officer following a distinguished career with Domino's. Consistent with its multi-year succession planning process, the Domino's Board of Directors has appointed Joe Jordan, currently Chief Operating Officer and President – Domino's U.S., as Chief Executive Officer, effective

Howard Wilson Retires as Chief Financial OfficerPagerDuty, Inc. (NYSE:PD), a leader in AI-first operations management, today announced that Eric Prengel has joined the company as Chief Financial Officer. Prengel will oversee our Finance and Business Operations organization at PagerDuty, including all Finance and Accounting Functions, Global Business Operations, Corporate Strategy, Corporate Development, and Investor Relations with a focus on advancing business objectives as PagerDuty enters its next phase of growth.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260622580002/en/Eric Prengel, Chief Financial Officer, PagerDutyPrenge

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ:CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 2,500,000 shares of common stock at a purchase price of $4.00 per share. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering were $10 million, before deducting placement agent fees and other offering expenses payable by the Company. The Company intends to use the net procee

ZUG, Switzerland, June 22, 2026 – MoonLake Immunotherapeutics (NASDAQ:MLTX) ("MoonLake"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases, today announced a proposed public offering of $150 million of its Class A ordinary shares and, in lieu of Class A ordinary shares to certain investors that so choose, pre-funded warrants to purchase Class A ordinary shares. In addition, MoonLake is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $22.5 million of its Class A ordinary shares offered in the proposed offering at the public offering price, less the under

LEXINGTON, Mass. and AMSTERDAM, June 22, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced a $150 million underwritten public offering of its ordinary shares and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase its ordinary shares. All securities to be sold in the offering will be offered by uniQure. In addition, uniQure intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of its ordinary shares on the same terms and conditions. The offering is subject to market and othe

Definium Therapeutics, Inc. (NASDAQ:DFTX) (the "Company" or "Definium"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it intends to offer and sell, subject to market conditions, $500 million of its common shares and, to certain investors, pre-funded warrants to purchase common shares in an underwritten public offering. In addition, Definium intends to grant the underwriters an option for a period of 30 days to purchase up to $75 million of its common shares at the public offering price, less underwriting discounts and commissions. All of the co

MIAMI, June 22, 2026 (GLOBE NEWSWIRE) -- Sharplink, Inc. (NASDAQ:SBET) ("Sharplink" or the "Company"), one of the world's largest corporate holders of Ether ("ETH") and a prominent industry advocate of Ethereum adoption, today announced that it has entered into a securities purchase agreement with an institutional investor (the "Investor") for the purchase and sale of 10,013,351 shares of its common stock, par value $0.0001 per share (the "Shares), and accompanying warrants to purchase up to 10,013,351 shares of common stock (the "Warrants"), at a combined purchase price of $7.49 per Share and Warrant. The purchase price represents a 41% premium to the Company’s closing share price of $5.2

ROCHESTER, NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (NASDAQ:OPTX), a leading provider of mission-critical technologies for vibrant end-markets - defense tech, space tech, and biomed tech today announced it received nearly $4 million in U.S. life sciences purchase orders.  As the quality of healthcare in the U.S. advances, Syntec Optics is playing a pivotal role in providing the high-precision optical products required for existing and next-generation technologies.  Building on the previously announced $4.6 million in orders for laser blood analysis optics used in nearly every leading clinic and hospital, these additional contracts for a diverse set of other products furt

Bitmine owns 4.7% of the total ETH coin supply of 120.7 millionBitmine is 94% of the way to the 'Alchemy of 5%' in just 11 monthsBitmine's Series A Preferred Stock is trading on the NYSE under the symbol BMNPBitmine has 4,718,677 staked ETH, representing $8.2 billion at $1,733 per ETH. MAVAN (Made in America VAlidator Network) is a premier Ethereum staking destination for BMNR and institutional investorsBitmine owns $104 million of Eightco (NASDAQ:ORBS), now one of the only publicly listed equities in the world to provide investors indirect exposure to OpenAIBitmine Crypto + Total Cash Holdings & Marketable Securities + "Moonshots" total $10.7 billion, including 5.67 million ETH tokens, tota

MIAMI BEACH, FL, June 22, 2026 /CNW/ - GFL Environmental Inc. (NYSE:GFL) (TSX:GFL) ("GFL" or the "Company") today announced that it is planning to commence, subject to market and other conditions, a private offering (the "Notes Offering") of US$750 million in aggregate principal amount of senior notes due 2031 (the "Notes"). The Notes will be issued by a U.S. wholly owned subsidiary of GFL and will be guaranteed by GFL and certain of its other subsidiaries. GFL intends to use the proceeds from the Notes Offering to repay amounts drawn on its revolving credit facility and to fund fees and expenses, with a view to maximizing its

Shareholders adopt all proposals, co-founder Dr. Jurgi Camblong elected as Executive Chairman of the Board, Ross Muken elected as new member of the Board ahead of his appointment as CEO effective July 1, 2026ROLLE, Switzerland, June 22, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, today announced that its 2026 Annual General Meeting of shareholders adopted all proposals on the agenda, electing Dr. Jurgi Camblong as the Executive Chairman of the Board of Directors with 99.79% of the votes, and Ross Muken as a member of the Board of Directors for the first time with 99.88% of the votes. Mr. Muken will assume the role of Chief Executive Of

Newly Constructed Phase 2 now 100% LeasedFurther Solidifies Innovation Park as Boston's Premier Advanced Manufacturing DestinationBOSTON, June 22, 2026 /PRNewswire/ -- IQHQ, Inc. today announced that AdvanCell has signed a long-term ~128,000 square foot lease for the entire 1 Corporate Drive building at Innovation Park, IQHQ's premier life science and advanced manufacturing campus in Andover, Massachusetts. The transaction is one of the largest life science leases in Greater Boston this year and brings the newly constructed Phase 2 of Innovation Park to 100% leased. AdvanCell's decision to locate at Innovation Park after a broad search and competitive process underscores the strength of the

VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. ("Westport") (TSX:WPRT, NASDAQ:WPRT), today announced that it has entered into a definitive securities purchase agreement for the purchase and sale of 4,854,369 common shares (or pre-funded warrants in lieu thereof) in a registered direct offering and, in a concurrent private placement, warrants to purchase up to 4,854,369 common shares, priced at-the-market under Nasdaq rules. The combined effective purchase price for each common share (or pre-funded warrant in lieu thereof) and associated private placement warrant is US$2.06. The private placement warrants have an exercise price of US$2.06 per commo

Sable Offshore Corp. (NYSE:SOC, "Sable", or the "Company")) today announced that the Company and Exxon Mobil Corporation ("Exxon") entered into an amendment (the "Amendment") to the Senior Secured Term Loan Agreement (the "Senior Secured Term Loan") to, among other things, extend the Maturity Date, and agreed to a limited waiver of the Company’s P&A Financial Security obligations in Section 11.18 (c) (the "Limited Waiver") of the Company’s November 1, 2022 Purchase and Sale Agreement (the "PSA") with Exxon and Mobil Pacific Pipeline Company ("MPPC" and, together with Exxon , the "Sellers"). The Amendment extends the Maturity Date of the Senior Secured Term Loan to the earlier to occur of

Ambiq Micro, Inc. ("Ambiq") (NYSE:AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the commencement of an underwritten public offering of 1,800,000 shares of its common stock. In addition, Ambiq expects to grant the underwriters a 30-day option to purchase up to an additional 270,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. BofA Securities and UBS Investment Bank are acting as joint lead book-runn

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common stock upon conversion of the notes JUPITER, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) ("Ligand") announced today its intention to offer $550.0 million aggregate principal amount of convertible senior notes due 2031 (the "notes") in a private placement (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "

KUALA LUMPUR, Malaysia, June 19, 2026 /PRNewswire/ -- Agroz Inc. (NASDAQ:AGRZ) ("Agroz" or the "Company"), an innovative, fully vertically integrated agricultural technology company designing, building, managing and operating Controlled Environment Agriculture ("CEA") vertical farms, today announced that it has been awarded the Superbrands 2026 title. The recognition highlights Agroz's strong brand reputation, market leadership and continued commitment to excellence within the agricultural technology and fresh produce industries. The Superbrands Award is one of the world's most

BOSTON and ROLLE, Switzerland, June 19, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced underwritten public offering with total gross proceeds of $57.5 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company. As a result of strong investor demand, the offering was oversubscribed, and the underwriters fully exercised their option to purchase an additional 1,578,900 ordinary shares at the public offering price, less the underwriting discounts and commissions. The Company sold 12,104,900 ordinary shares at a price to the

MFS Investment Management ("MFS") announced today that effective after market close on July 2, 2026 (the "Effective Date"), abrdn Inc. ("Aberdeen"), the US Subsidiary of Aberdeen Investments, the global specialist asset manager, will replace MFS as the investment adviser of the MFS Government Markets Income Trust (NYSE:MGF) and the MFS Intermediate Income Trust (NYSE:MIN) (each a "Fund" and collectively, the "Funds"). Additionally on the Effective Date, five new trustees will be appointed to each Fund's Board of Trustees and each Fund's current trustees will resign. Following the Effective Date, it is intended that MGF's name will change from "MFS Government Markets Income Trust" to "Aber

First Trust High Yield Opportunities 2027 Term Fund (the "Fund") (NYSE:FTHY) has declared the Fund's regularly scheduled monthly common share distribution in the amount of $0.125 per share payable on July 27, 2026, to shareholders of record as of July 1, 2026. The ex-dividend date is expected to be July 1, 2026. The monthly distribution information for the Fund appears below. First Trust High Yield Opportunities 2027 Term Fund (FTHY): Distribution per share: $0.125 Distribution Rate based on the June 17, 2026 NAV of $14.10: 10.64% Distribution Rate based on the June 17, 2026 closing market price of $13.52: 11.09% This distribution will c

– Extraordinary General Meeting of Perceptive Shareholders Scheduled for July 9, 2026NEW YORK and BRISBANE, Calif., June 18, 2026 /PRNewswire/ -- Perceptive Capital Solutions Corp ("PCSC") (NASDAQ:PCSC), a special purpose acquisition company ("SPAC") sponsored by an affiliate of Perceptive Advisors, and Freenome Holdings, Inc. ("Freenome"), an early cancer detection company developing blood-based screening tests, today announced that the registration statement on Form S-4 (File No. 333-2953772) (as amended, the "Registration Statement"), filed by PCSC and Freenome, relating to the previously announced business combination among PCSC, Freenome and the other parties thereto (the "Business Comb

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- BlockchAIn Digital Infrastructure, Inc. (NYSE:AIB) ("BlockchAIn" or the "Company"), a developer and operator of digital infrastructure focused on artificial intelligence ("AI") workloads, today announced that the underwriter of its public offering of common stock has exercised in full its option to purchase an additional 4,999,999 shares of its common stock at the public offering price of $1.65 per share less the underwriting discounts and commissions, resulting in additional gross proceeds of approximately $8.25 million. Including the full exercise of the option, the Company sold a total of 38,333,333 shares of its common stock in the offering,

Jiangsu, China, June 18, 2026 (GLOBE NEWSWIRE) -- Mingteng International Corporation Inc. (NASDAQ:MTEN) (the "Company") today announced the closing of its previously announced registered direct offering of 1.48 million Class A ordinary shares, par value $0.00005 per share ("Class A Ordinary Shares"), at a purchase price of $2.00 per share, and pre-funded warrants to purchase Class A Ordinary Shares at an original exercise price of $2.00, with $1.99995 of the original exercise price pre-funded at the closing, and a remaining exercise price of $0.00005 per Class A Ordinary Share.  In a concurrent private placement, the Company also issued to the same investors unregistered warrants to purch

Record High Revenue, Adjusted Income from Operations, and Net Income, Up 10.0%, 1.0%, and 1.5% Year-over-Year, Respectively[1]TOKYO, June 18, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (NASDAQ:LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement and Japan's leading operator of children's sports schools and school club activity support businesses, today announced its unaudited financial results for the three months ended March 31, 2026.  First Quarter of Fiscal Year 2026 Financial HighlightsRevenue was JPY3.0 billion ($18.6 million), an increase of 10.0% from JPY2.7 billion for the same period last year.Income from operations w

JERSEY CITY, N.J., June 18, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, closed its previously announced public offering of securities as described below for aggregate gross proceeds to the Company of $3.2 million, before deducting agent fees and other estimated expenses payable by the company.

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)),a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced the closing of its previously announced public offering of securities as described below for aggregate gross proceeds to the Company of $3.2 million, before deducting agent fees and other estimated expenses payable by the company.The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price of $0.80 per share (or $0.793 per pre-funded warrant). Each pre-funded warrant will be exercisable for

BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ:CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced that it has entered into definitive agreements for the purchase and sale of 2,500,000 shares of common stock at a purchase price of $4.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about June 22, 2026, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from the o

PORT ANGELES, Wash., June 18, 2026 (GLOBE NEWSWIRE) -- First Fed Bank ("First Fed"), a wholly owned subsidiary of First Northwest Bancorp (NASDAQ:FNWB) ("First Northwest" or the "Company"), has named Chris Walsh as its new Chief Banking Officer, bringing more than 40 years of banking leadership and a track record of helping community banks grow and deepen their impact in the communities they serve. As Chief Banking Officer, Walsh will oversee all of First Fed's banking functions, helping advance First Fed's long-term strategy of building a stronger, more responsive community bank for business and retail customers, employees and local communities across Northwest Washington. Walsh is the s

Eightco treasury composition as of June 18, 2026: $90M OpenAI equity (indirect), $18M Beast Industries equity, 16,278 ETH, 283 million WLD holdings, and $149M cash and equivalents, totaling approximately $472 millionOpenAI recently announced that it submitted a confidential S-1, setting itself up for an initial public offeringWorld offers a solution to the 'double human' problem in a world proliferating with deepfakes Eightco provides indirect exposure to some of the most innovative private companies including OpenAI and Beast IndustriesEASTON, Pa., June 18, 2026 /CNW/ -- Eightco Holdings Inc. (NASDAQ:ORBS) ("Eightco" or the "Company") today provided an update on its total holdings, highligh

OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- TryHard Holdings Limited ("TryHard" or the "Company") (NASDAQ:THH), a lifestyle entertainment platform in Japan, today announced the expansion of its nationwide footprint with 23 venues operating across 13 cities, following three market entries since its initial public offering in 2025. TryHard currently operates 23 entertainment venues across Japan, with a strong presence in major metropolitan areas, including: Osaka: G2 OSAKA, AMMONA, OWL OSAKA, BAMBI, CRAZYLAND BY CHEVAL, PICCADILLY PREMIUM and GIRAFFEKyoto: KITSUNE KYOTO and WHIZZ KYOTONagoya: ORCA NAGOYA, CLUB SANGO (Nagoya) and CLUB STARTokyo: WARP SHINJUKU and CROSS ROPPONGISapporo:

REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO, ALVO-SDB)) ("Alvotech" or the "Company"), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the "Offering") of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were offered by Alvotech. Before deductin

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ:LEGN) ("Legend Biotech" or the "Company"), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares ("ADSs"), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross proceeds to Legend Biotech from the offering, before deducting

Liberty Media Corporation ("Liberty") (NASDAQ:FWONA, FWONK)) announced today that MotoGP Sports Entertainment Group, S.L. ("MotoGP") closed the repricing of its first lien Term Loan B, first lien Term Loan A and first lien revolving credit facility on June 17, 2026. MotoGP is a subsidiary of Liberty and is the exclusive commercial rights holder of the FIM MotoGP™ World Championship.MotoGP repriced the previous €800 million Term Loan B with a maturity of August 18, 2032 with a new €720 million Term Loan B due August 18, 2032, the previous $231 million Term Loan A with a maturity of August 18, 2030 with a new $209 million Term Loan A with a maturity of August 18, 2030 and the previous €100 mil

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ:LEGN) ("Legend Biotech" or the "Company"), a global leader in cell therapy, today announced that it has commenced an underwritten public offering of $225 million of American Depositary Shares ("ADSs"), each representing two ordinary shares of the Company. All of the ADSs will be offered by Legend Biotech. Legend Biotech also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ADSs sold in the public offering at the public offering price, less underwriting discounts and commissions. The offering is subject to market conditions, and there can be no assurance as to

Nyxoah Receives $15 Million from the European Investment Bank Non-dilutive debt funding complements the Company's June equity raise, bringing total capital raised to $110 million Mont-Saint-Guibert, Belgium – June 17, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced that it has received $15 million (€13.8 million) in proceeds from the second tranche of its loan facility with the European Investment Bank (EIB). The drawdown follows the recent confirmation that the Company had satisfied the predefined criteria requ

Jiangsu, China, June 17, 2026 (GLOBE NEWSWIRE) -- Mingteng International Corporation Inc. (NASDAQ:MTEN) (the "Company") today announced the pricing of its registered direct offering of 1.48 million Class A ordinary shares, par value $0.00005 per share ("Class A Ordinary Shares"), at a purchase price of $2.00 per share, and pre-funded warrants to purchase Class A Ordinary Shares at an original exercise price of $2.00, with $1.99995 of the original exercise price pre-funded at the closing, and a remaining exercise price of $0.00005 per Class A Ordinary Share.  In a concurrent private placement, the Company also issued to the same investors unregistered warrants to purchase up to 1.48 millio

REDMOND, Wash., June 17, 2026 (GLOBE NEWSWIRE) -- Data I/O Corporation (NASDAQ:DAIO) (the "Company"), the leading global provider of data provisioning solutions for flash memory, microcontrollers and security ICs, today announced the closing of its previously announced definitive securities purchase agreement with two institutional investors for aggregate gross proceeds of $9 million, before placement agent fees and offering expenses. The financing includes the issuance of common stock and warrants, and a convertible debenture. Pursuant to the terms of the securities purchase agreement, the Company issued 869,840 shares of common stock, convertible debentures in the aggregate principal am

The presentation is now available on demand, outlining IQM's growth strategy, technology roadmap, commercial momentum, and vision for the future of quantum computing. IQM Quantum Computers Oy (f/k/a IQM Finland Oy), a global leader in full-stack superconducting quantum computers ("IQM," "IQM Quantum Computers" or the "Company"), today announced that its Capital Markets Day presentation is now available on IQM's investor site at https://iqm.tech/ir/IQM-CapitalMarketDay-2026.pdf, following the event hosted at the Nasdaq MarketSite in New York City on June 15, 2026. The final edited webcast will be posted to and available on the Company's investor relations website in the coming days. This

JERSEY CITY, N.J., June 17, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, priced a Public Offering of securities as described below for aggregate gross proceeds to the Company of $3.2 million, before deducting agent fees and other estimated expenses payable by the company. The offering consists of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced that it has priced a Public Offering of securities as described below for aggregate gross proceeds to the Company of $3.2 million, before deducting agent fees and other estimated expenses payable by the company. The offering consists of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price of $0.80 per share (or $0.793 per pre-funded warrant). Each pre-funded warrant will be exercisable for one share of co

Issued on behalf of General Fusion Inc.As AI and electrification send power demand soaring, the race to commercialize fusion has collided with the public markets — and the company TIME just ranked the World's Top GreenTech company is heading for the Nasdaq.NEW YORK, June 17, 2026 /CNW/ -- USA News Group News Commentary — For half a century, commercial fusion energy has carried a punchline: it is always "twenty years away." The physics is the closest thing humanity has to a perfect energy source — the reaction that powers the sun, fueled by hydrogen, producing no carbon emissions and no long-lived radioactive waste — but turning it into electricity on the grid has defeated generations of scie

JACKSONVILLE, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. ("Duos" or the "Company") (NASDAQ:DUOT), a leading provider of adaptive, modular, and scalable Edge Data Center ("EDC") solutions, today announced an underwritten registered direct offering of 2,000,000 shares of common stock and 3,800,000 pre-funded warrants at a price of $9.50 per share or warrant for total gross proceeds of approximately $55 million, before deducting underwriting discounts, commissions, and offering expenses. The registered direct offering was completed by a single large institutional investor, to support the Company's continued growth plans. The net proceeds from the offering will be u

Columbia, South Carolina--(Newsfile Corp. - June 17, 2026) - Elauwit Connection, Inc. (NASDAQ:ELWT) ("Elauwit" or the "Company"), a national managed services provider of turnkey broadband and property-wide WiFi networks serving multifamily, student housing, and senior living communities, today announced the appointment of Nick Jones as Chief Information Officer and Chief Operating Officer. "Nick brings deep experience providing managed services critical to the guest experience across a broad portfolio of hotel properties, combining entertainment, connectivity, infrastructure and management into a comprehensive platform solution," said Dan McDonough, Executive Chairman. "His work integrating

Transaction expected to accelerate EigenQ's mission to develop and commercialize quantum technologies across security, artificial intelligence, communications, sensing, and computingTransaction HighlightsTransaction values EigenQ at a pro forma enterprise value of approximately $3 billion;Transaction supported by approximately $215 million held in SVAQ's trust account, prior to shareholder redemptions and transaction expenses;EigenQ is a Quantum Technology Company developing and commercializing foundational technologies across Quantum Security, Quantum AI, Quantum Communications, Quantum Sensing, and Quantum Computing;Driven by government mandate and market demand, EigenQ has developed readi

Pattern Group Inc. (NASDAQ:PTRN) ("Pattern"), a leader in accelerating brands on global ecommerce marketplaces leveraging proprietary technology and AI, today announced the pricing of a public offering of 8,000,000 shares of Series A common stock by an entity affiliated with Knox Lane LP, a pre-IPO stockholder of Pattern (the "Selling Stockholder"), at a public offering price of $19.00 per share. The Selling Stockholder granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Series A common stock. The Selling Stockholder will receive all of the net proceeds from the offering and Pattern will not receive any proceeds. The offering is expected to close on

BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of $4.75 per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately $50 million. All of the ordinary shares to be sold in the proposed offering will be sold by the Company. In addition, the Company has granted the underwriters a 30-day option to purchase up to 1,578,900

ACHESON, Alberta, June 16, 2026 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. ("NACG") (TSX:NOA, NYSE:NOA) announced today that it has successfully closed its previously announced private placement offering (the "Offering") of $200 million aggregate principal amount of 7.00% Senior Unsecured Notes due June 16, 2031 (the "Notes"). As previously stated, NACG will utilize the proceeds of the Offering to repay indebtedness under its existing Credit Agreement, and for general corporate purposes. The Notes were offered for sale in Canada on a private placement basis pursuant to certain prospectus exemptions. The Notes have not been registered under the United States Securities Act

BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwritten public offering of its ordinary shares. The Company also expects to grant the underwriters an option to purchase up to an additional 15% of the ordinary shares at the public offering price, less the underwriting discount. All of the ordinary shares to be sold in the proposed offering will be sold by the Company. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offer

SOUTH SAN FRANCISCO, Calif., June 16, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced the closing of its license agreement for VEPPANUTM (vepdegestrant), following the early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976 and satisfaction of other customary closing conditions. Rigel previously announced it entered into an exclusive, global license agreement with Arvinas, Inc. (Arvinas) and Pfizer Inc. (Pfizer) to develop, manufacture and commercialize VEPPANU. VEPPANU is approved by the U.S. Food and Drug Administration (FDA) f

CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE:CVM), a clinical stage cancer immunotherapy company, today announced the closing of its best-efforts offering of 2,500,000 shares of its common stock. Each share of common stock was sold at an offering price of $1.00 per share. Total gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, were approximately $2.5 million.The Company intends to use the net proceeds from the offering to fund the continued development of Multikine*, general corporate purposes, and working capital.ThinkEquity acted as the sole placement agent for the offering.The securities were offered and sold pursuant to a

Co-Founder and Chief Executive Officer Dr. Najam Kidwai Highlights Portfolio Growth, Initial Liquidity Events, the Share Repurchase Program, and Expanded Investor Engagement C1 Fund Inc. (NYSE:CFND) ("C1 Fund" or the "Fund"), a publicly traded closed-end fund providing investors with exposure to high-growth pre-IPO private companies across the digital asset economy, today issued a letter to shareholders from Dr. Najam Kidwai, Chief Executive Officer. Dear Shareholders, When C1 Fund listed on the New York Stock Exchange in August 2025, our objective was straightforward: give public market investors a single, exchange-listed vehicle with concentrated exposure to leading late-stage, pre-